The stock market, while generally bullish all year, is nothing if not volatile. Billionaire Elon Musk, whose fortune is mostly tied up in Tesla (NASDAQ: TSLA) stock, dropped from richest person in the...
‘I have been plagued by enormous guilt and regret:’ I tried to care for my late father, but I gave up. How can I ever forgive myself?
‘He was a good father, except everything had to be his way. But I know I was a cruel and horrible son.’
- HealthThe Week
Researchers reported Monday in the journal Science that a drug developed to fight multiple myeloma has proved 27.5 times more effective at treating COVID-19 than remdesivir in laboratory studies with infected human lung and kidney cells. The drug, Aplidin or Plitidepsin, was also effective at fighting COVID-19 in lab mice. Aplidin was developed in Spain from a tubular, plantlike marine animal called a sea squirt. It has gone through a Phase II trial against COVID-19 and is awaiting a Phase III trial. Researchers at the University of California, San Francisco, started exploring Aplidin's use as a treatment for COVID-19 in March. Instead of looking through databases of existing drugs to find one that targeted the virus, the Milwaukee Journal Sentinel reports, the UC San Francisco team sought out drugs that would protect key human proteins from being hijacked by the coronavirus. Experts not involved in the study said the research was promising but needed confirmation in human trials. Effective treatments will be crucial for keeping down the death toll as new, more contagious variants of the coronavirus emerge and spread. The approved COVID-19 vaccines appear slightly less effective against the new strains, and scientists have yet to show that vaccinated people stop transmitting the coronavirus. A second study, not yet published or peer-reviewed, suggests that Aplidin is equally effective against one of the new strains that had spread throughout Britain. "Work on treatments has been ongoing since the outbreak began and we have seen the benefits," Chris Beyrer, professor of public health at Johns Hopkins Bloomberg School of Public Health, told the Journal Sentinel. "Survival is actually better than it was in March, April, May." More stories from theweek.comMitch McConnell is the GOATWho is the Cinderella in the GameStop fairy tale?The left's fake Senate majority
- EntertainmentDr. Phil CBS
Video‘If He Makes My Daughter Cry – I’m Coming For Him,’ Says Mom About Daughter’s 62-Year-Old Boyfriend
Bill, a 62-year-old wealthy real estate developer, and Bri, a 23-year-old former restaurant hostess, claim that, despite their different backgrounds and almost 40-year age difference, they have great communication and a “healthy relationship.” The couple, who have been together for four years and are currently featured on the Lifetime television series Marrying Millions, admit that not everyone in their extended families wants to see them together. “Bill and I put up with each other, but I’m just more outspoken, and he’s more fake,” says Bri’s mother, Sharon. “I’ve already given him fair warning. If he makes my daughter cry – I’m coming for him.” When Bill tells Sharon that he would never want to hurt Bri and says he’s “satisfied” with their relationship, how does Bri respond? Watch more from Tuesday’s Dr. Phil here. Dr. Phil airs Monday-Friday. Check here for your local listing. The new season of Marrying Millions premieres Wednesday, January 27, 2021. WATCH: ‘I Don’t Want Her To Get Hurt,’ Says Woman About Her Ex-Husband’s New Girlfriend TELL DR. PHIL YOUR STORY: Have an outrageous story that will shock Dr. Phil?